Biothera Pharmaceuticals Announces Data Demonstrating Unique Immune Response Profile Generated by Phase 2 Cancer Immunotherapy Imprime PGG

EAGAN, Minn.–(BUSINESS WIRE)–Biothera Pharmaceuticals will present data tomorrow demonstrating the unique immune response profile of its Phase 2 cancer immunotherapy drug at the EORTC-NCI-AACR symposium in Munich, Germany.
Source: BusinessWire-Primary

Biothera Pharmaceuticals Announces Data Demonstrating Unique Immune Response Profile Generated by Phase 2 Cancer Immunotherapy Imprime PGG